Sort
85,873 grants matching “alzheimers”
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial
$2,078,174Daniel F Hanley · Johns Hopkins University · R01 · FY2021 · AG
Child Maltreatment and Risk for Mild Cognitive Impairment and Alzheimer's Disease
$2,078,132Cathy Spatz Widom · John Jay College Of Criminal Justice · R01 · FY2019 · AG
Genetic Consortium for Late Onset Alzheimer's Disease
$2,078,005Richard Mayeux · Columbia University Health Sciences · U24 · FY2009 · AG
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology Associations
$2,077,693Paul A. Yushkevich · University Of Pennsylvania · RF1 · FY2023 · AG
PREVENTABLE Data Coordinating Center
$2,077,632Bradley G Hammill · Duke University · U19 · FY2023 · AG
Differential diagnosis of Parkinson's and multiple system atrophy in non-human primate models using a novel a-synuclein retinal contrast agent and AI-assisted analytics
$2,077,573Stella Sarraf · Amydis Diagnostics, Inc. · R44 · FY2021 · NS
GENERAL CLINICAL RESEARCH CENTER
$2,077,270Richard N Fine · State University New York Stony Brook · M01 · FY2007 · RR
Emergency Care Redesign (ECR)
$2,075,775Joshua Chodosh · New York University School Of Medicine · U19 · FY2023 · AG
The role of neuronal hyperexcitability and proteostasis in Alzheimer's disease
$2,075,563S. Abid Hussaini · Winifred Masterson Burke Med Res Inst · RF1 · FY2024 · AG
Emergency General Surgery Delirium Recovery Model: A Collaborative Care Intervention
$2,075,345Ben L Zarzaur · University Of Wisconsin-Madison · R01 · FY2022 · AG
Genomic regulation of immune response in neurodegeneration in mice
$2,074,665Han-Yu Shih · National Eye Institute · ZIA · FY2024 · EY
5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical Trial
$2,074,631Joe Verghese · Albert Einstein College Of Medicine · U01 · FY2023 · NS
Molecular signaling during development and maturation of the nervous system
$2,073,197David Talmage · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
Lifeâs end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study
$2,072,617Jacobo E. Mintzer · Medical University Of South Carolina · R01 · FY2025 · AG
Assessing Brain Microstructure in Alzheimer's Disease with Advanced Diffusion MRI
$2,071,501Jens H Jensen · Medical University Of South Carolina · RF1 · FY2018 · AG
Perimenopause in Brain Aging and Alzheimer's Disease
$2,070,810Roberta Diaz Brinton · University Of Arizona · P01 · FY2018 · AG
Acquisition of a High-Field Dual Source FTICR-MS for Pharmaceutical Research
$2,070,000Lingjun Li · University Of Wisconsin-Madison · S10 · FY2011 · RR
Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors
$2,069,619Robert A Stern · Boston University Medical Campus · U01 · FY2020 · NS
Decoding the BETA-arrestin2-LMBRD2 cascade in ALPHA-synuclein pathogenesis.
$2,069,215Junga "alexa" Woo · Case Western Reserve University · RF1 · FY2024 · NS
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,069,209Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Antecedent Biomarkers For AD: The Adult Children Study
$2,068,818John Morris · Washington University · P01 · FY2020 · AG
Central Nervous System Drug Delivery Techniques
$2,068,109Russell Lonser · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
Project 2: Aging Healthy Together: Precision Profiles of Resilience and Risk
$2,068,060Lee Ryan · University Of Arizona · U19 · FY2022 · AG
DETECT-AD: Digital Evaluations and Technologies Enabling Clinical Translation for Alzheimer's Disease
$2,068,051Jeffrey A Kaye · Oregon Health & Science University · R56 · FY2022 · AG
Alzheimer's Disease and Animal Models
$2,067,655Donald L Price · Johns Hopkins University · P50 · FY2009 · AG